Clinical trial
Assessment of Mitral Doppler as a Predictor of Respiratory Worsening After Vascular Filling for ICU Patients With Mechanical Ventilation. The EVALDM Study
NCT03447366 is registered in ClinicalTrials.gov with Centre Hospitalier Metropole Savoie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Mitral Doppler as a Predictor of Respiratory Worsening After Vascular Filling for ICU Patients With Mechanical Ventilation. The EVALDM Study
- Lead sponsor
- Centre Hospitalier Metropole Savoie
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 30, 2018
- Completion date
- April 30, 2022
- Enrollment
- 87 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
echocardiography, respiration, artificial, vascular filling